Promoting physical activity through supervised vs motivational behavior change interventions in breast cancer survivors on aromatase inhibitors (PAC-WOMAN): protocol for a 3-arm pragmatic randomized controlled trial

BACKGROUND: Aromatase inhibitors (AI) are frequently used to treat hormone-receptor-positive breast cancer, but they have multiple adverse effects (e.g., osteoporosis, arthralgia), resulting in premature therapy discontinuation/switch. Physical activity (PA) can attenuate these negative effects and...

Descripción completa

Detalles Bibliográficos
Autores principales: Carraça, Eliana V., Rodrigues, Bruno, Franco, Sofia, Nobre, Inês, Jerónimo, Flávio, Ilharco, Vítor, Gabriel, Fernanda, Ribeiro, Leonor, Palmeira, António L., Silva, Marlene N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324133/
https://www.ncbi.nlm.nih.gov/pubmed/37407950
http://dx.doi.org/10.1186/s12885-023-11137-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324133/
https://www.ncbi.nlm.nih.gov/pubmed/37407950
http://dx.doi.org/10.1186/s12885-023-11137-1

Ejemplares similares